C-reactive protein and postmenopausal breast cancer risk: results from the E3N cohort study

By Dossus Laure   Jimenez-Corona Aida   Romieu Isabelle   Boutron-Ruault Marie-Christine   Boutten Anne   Dupré Thierry   Fagherazzi Guy   Clavel-Chapelon Francoise   Mesrine Sylvie  

Cancer Causes and Control, Vol. 25, Iss. 4, 2014-04 ,pp. : 533-539

Springer Publishing Company

Access to resources Recommend Favorite

Insulin-like growth factor-I and C-reactive protein during pregnancy and maternal risk of non-epithelial ovarian cancer: a nested case-control study

By Toriola Adetunji  

Cancer Causes and Control, Vol. 22, Iss. 11, 2011-11 ,pp. : 1607-1611

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapy

By                            

Oncology Letters, Vol. 8, Iss. 2, 2014-01 ,pp. : 881-885

Spandidos Publications

Access to resources Recommend Favorite

Survival in common cancers defined by risk and survival of family members

By Ji Jianguang  

Oncology Reviews, Vol. 5, Iss. 1, 2011-03 ,pp. : 13-20

Springer Publishing Company

Access to resources Recommend Favorite

Eating habits and risk of esophageal cancers: a population-based case–control study

By Ibiebele Torukiri  

Cancer Causes and Control, Vol. 21, Iss. 9, 2010-09 ,pp. : 1475-1484

Springer Publishing Company

Access to resources Recommend Favorite